Search results
Showing 31 to 45 of 281 results for covid-19
This guideline covers assessment of people aged 16 and over with symptoms and signs of acute respiratory infection (bacterial or viral) at first remote or in-person contact with NHS services. It also covers the initial management of any infections. It aims to support healthcare practitioners in making sure that people’s treatment follows the best care pathway. It forms part of a suite of work on virtual wards being undertaken by NICE.
systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are...
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)
This guideline covers the diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS (COPD–OSAHS overlap syndrome) in people over 16. It aims to improve recognition, investigation and treatment of these related conditions.
This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.
In development Reference number: GID-TA10664 Expected publication date: TBC
In development Reference number: GID-QS10113 Expected publication date: TBC
of post-COVID-19 syndrome? Any explanatory notes(if applicable) Source guidance details Comes from guidance COVID-19 rapid
In development Reference number: GID-QS10094 Expected publication date: 01 July 2026
critically ill and have, or have had, COVID-19 as part of their acute illness are associated with developing...
with cancer and COVID-19: Are people who have had radiotherapy recently (that is, within the 4 weeks preceding a diagnosis of...
people with cancer and COVID-19: Are people who have had SACT recently (that is, within the 4 weeks preceding a diagnosis of...
What is the efficacy and safety of remdesivir for people who have been vaccinated against COVID-19?
efficacy and safety of remdesivir for people who have been vaccinated against COVID-19? Any explanatory notes(if applicable) Suggested...
NG223/11 Question Impact of COVID-19: What is the medium-to long-term impact of the COVID-19 pandemic on children and...
Recommendation ID NG191/19 Question What is the clinical effectiveness and safety of vitamin D for treating COVID-19 in...
This guideline covers how to create the right conditions for mental wellbeing at work. It aims to promote a supportive and inclusive work environment, including training and support for managers and helping people who have or are at risk of poor mental health.